TRIFAROTENE
| Brand name | AKLIEF |
|---|---|
| Active ingredient | TRIFAROTENE |
| Strength | 0.005% |
| Dosage form | CREAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | October 2019 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9084778 | May 2033 | product |
| 9498465 | May 2033 | product |
| 7807708 | July 2031 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.